One such study by Sharafeldin and colleagues investigated the use of a 3D-printed microfluidic microarray capable of detecting desmoglein 3 (DSG3), a known metastatic biomarker for HNSCC, at ultralow concentrations (0.1 fg/mL) [65]. The gene discussed is DSG3; the disease is head and neck squamous cell carcinoma.